194 related articles for article (PubMed ID: 22300031)
1. Traumatic brain injury: central and peripheral role of α7 nicotinic acetylcholine receptors.
Kelso ML; Oestreich JH
Curr Drug Targets; 2012 May; 13(5):631-6. PubMed ID: 22300031
[TBL] [Abstract][Full Text] [Related]
2. Traumatic brain injury elicits similar alterations in α7 nicotinic receptor density in two different experimental models.
Hoffmeister PG; Donat CK; Schuhmann MU; Voigt C; Walter B; Nieber K; Meixensberger J; Bauer R; Brust P
Neuromolecular Med; 2011 Mar; 13(1):44-53. PubMed ID: 20857232
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury.
Verbois SL; Scheff SW; Pauly JR
J Neurotrauma; 2002 Dec; 19(12):1569-85. PubMed ID: 12542858
[TBL] [Abstract][Full Text] [Related]
4. The pathophysiology of traumatic brain injury in alpha7 nicotinic cholinergic receptor knockout mice.
Kelso ML; Wehner JM; Collins AC; Scheff SW; Pauly JR
Brain Res; 2006 Apr; 1083(1):204-10. PubMed ID: 16545784
[TBL] [Abstract][Full Text] [Related]
5. High therapeutic potential of positive allosteric modulation of α7 nAChRs in a rat model of traumatic brain injury: proof-of-concept.
Gatson JW; Simpkins JW; Uteshev VV
Brain Res Bull; 2015 Mar; 112():35-41. PubMed ID: 25647232
[TBL] [Abstract][Full Text] [Related]
6. Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction.
Verbois SL; Hopkins DM; Scheff SW; Pauly JR
Neuroscience; 2003; 119(4):1199-208. PubMed ID: 12831873
[TBL] [Abstract][Full Text] [Related]
7. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
Ma KG; Qian YH
Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
[TBL] [Abstract][Full Text] [Related]
8. Traumatic brain injury reduces hippocampal alpha7 nicotinic cholinergic receptor binding.
Verbois SL; Sullivan PG; Scheff SW; Pauly JR
J Neurotrauma; 2000 Nov; 17(11):1001-11. PubMed ID: 11101204
[TBL] [Abstract][Full Text] [Related]
9. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
[TBL] [Abstract][Full Text] [Related]
10. The alpha7 nicotinic acetylcholine receptor in neuronal plasticity.
Broide RS; Leslie FM
Mol Neurobiol; 1999 Aug; 20(1):1-16. PubMed ID: 10595869
[TBL] [Abstract][Full Text] [Related]
11. Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes.
Jones IW; Westmacott A; Chan E; Jones RW; Dineley K; O'Neill MJ; Wonnacott S
J Mol Neurosci; 2006; 30(1-2):83-4. PubMed ID: 17192639
[TBL] [Abstract][Full Text] [Related]
12. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
Hernandez CM; Dineley KT
Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
[TBL] [Abstract][Full Text] [Related]
13. Activation of Alpha 7 Cholinergic Nicotinic Receptors Reduce Blood-Brain Barrier Permeability following Experimental Traumatic Brain Injury.
Dash PK; Zhao J; Kobori N; Redell JB; Hylin MJ; Hood KN; Moore AN
J Neurosci; 2016 Mar; 36(9):2809-18. PubMed ID: 26937017
[TBL] [Abstract][Full Text] [Related]
14. Positive allosteric modulation of the α7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury.
Titus DJ; Johnstone T; Johnson NH; London SH; Chapalamadugu M; Hogenkamp D; Gee KW; Atkins CM
PLoS One; 2019; 14(10):e0223180. PubMed ID: 31581202
[TBL] [Abstract][Full Text] [Related]
15. Methyllycaconitine: a non-radiolabeled ligand for mapping α7 neuronal nicotinic acetylcholine receptors - in vivo target localization and biodistribution in rat brain.
Nirogi R; Kandikere V; Bhyrapuneni G; Saralaya R; Muddana N; Komarneni P
J Pharmacol Toxicol Methods; 2012 Jul; 66(1):22-8. PubMed ID: 22609758
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
[TBL] [Abstract][Full Text] [Related]
17. Recent development of radioligands for imaging α7 nicotinic acetylcholine receptors in the brain.
Toyohara J; Wu J; Hashimoto K
Curr Top Med Chem; 2010; 10(15):1544-57. PubMed ID: 20583992
[TBL] [Abstract][Full Text] [Related]
18. Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling.
Parikh V; Ji J; Decker MW; Sarter M
J Neurosci; 2010 Mar; 30(9):3518-30. PubMed ID: 20203212
[TBL] [Abstract][Full Text] [Related]
19. α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties.
Thomsen MS; Zwart R; Ursu D; Jensen MM; Pinborg LH; Gilmour G; Wu J; Sher E; Mikkelsen JD
PLoS One; 2015; 10(6):e0130572. PubMed ID: 26086615
[TBL] [Abstract][Full Text] [Related]
20. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.
Mousavi M; Hellström-Lindahl E; Guan ZZ; Shan KR; Ravid R; Nordberg A
Neuroscience; 2003; 122(2):515-20. PubMed ID: 14614915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
